Name: Oramed Pharmaceuticals Inc. (ORMP) Balance Sheet
Creator: FinSpry

Oramed Pharmaceuticals Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Oramed Pharmaceuticals Inc. (ORMP) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 2024	Dec 2023	Dec 2022	Aug 2021	Aug 2020	Aug 2019	Aug 2018
Current Assets
Cash and Cash Equivalents	54.42	9.06	40.46	77.25	28.84	32.28	9.59
Short-Term Investments	87.51	152.99	115.26	16.90	0.00	0.00	0.00
Cash & Short-Term Investments	141.93	162.05	155.72	94.14	28.84	32.28	9.59
Accounts Receivable	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	1.29	0.54	1.39	1.20	0.01	0.02	0.00
Total Current Assets	143.22	162.58	157.11	95.34	40.51	33.32	31.04
Non-Current Assets
Property, Plant & Equipment (Net)	1.11	1.57	1.80	0.93	0.17	0.17	0.02
Long-Term Investments	10.91	56.37	2.70	6.69	0.00	0.00	0.00
Other Non-Current Assets	0.03	0.03	0.03	25.04	0.02	0.00	0.00
Total Non-Current Assets	12.06	57.97	4.53	32.66	4.12	1.34	16.36
Total Assets	155.28	220.55	161.64	128.00	44.63	34.66	47.40
Current Liabilities
Accounts Payable	0.79	0.55	2.18	2.61	1.70	2.54	2.10
Short-Term Debt	0.22	51.01	0.00	0.00	0.00	0.00	0.00
Accrued Liabilities	1.15	1.38	1.98	1.20	0.00	0.00	0.00
Deferred Revenue	0.00	0.00	1.34	2.70	0.00	0.00	0.00
Other Current Liabilities	1.48	0.06	0.01	0.04	7.18	0.06	0.00
Total Current Liabilities	5.69	53.21	5.75	6.68	4.54	5.31	4.55
Non-Current Liabilities
Long-Term Debt	0.16	0.34	0.65	0.40	0.03	0.00	0.00
Deferred Tax Liabilities	0.00	0.01	0.01	0.01	0.00	0.00	0.00
Other Non-Current Liabilities	0.06	0.07	0.06	0.14	0.01	0.28	0.31
Total Non-Current Liabilities	4.25	4.44	4.74	4.80	7.22	9.96	11.73
Total Liabilities	9.93	57.66	10.49	11.48	11.75	15.27	16.29
Stockholders' Equity
Common Stock	0.48	0.49	0.48	0.42	0.00	0.00	0.00
Retained Earnings	-176.62	-157.56	-163.08	-114.85	-92.61	-81.10	-69.22
Accumulated Other Comprehensive Income	0.00	0.00	0.00	0.00	0.00	0.00	0.70
Additional Paid-in Capital	322.40	320.89	314.42	230.20	125.21	100.29	99.43
Minority Interest	-0.92	-0.93	-0.66	0.74	0.00	0.00	0.00
Shares Outstanding	39.92	40.34	39.56	35.29	0.00	0.00	0.00
Total Stockholders' Equity	146.27	162.89	151.81	116.52	32.88	19.39	31.11
Total Liabilities & Equity	155.28	220.55	161.64	128.00	44.63	34.66	47.40